MIRM

#1168

Mirum Pharmaceuticals, Inc. Common Stock

92.2900

+0.51%

Сектор:

Базовая:

Валюта прибыли:

Дневной диапазон

Годовой диапазон

Дневное изменение

+0.51%

Месячное изменение

-8.40%

6-месячное изменение

+31.60%

Годовое изменение

+31.60%

Предыдущее закрытие

91.8200

Open

92.1100

Bid

Ask

Low

92.1100

High

92.2900

Объем

133

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities -89.08 M-132.76 M-120.14 M-70.94 M10.32 M55.83 M 55.83 M Cash from investing activities 37.87 M48.55 M7.7 M-107.2 M-90.13 M-23.95 M -23.95 M Cash from financing activities 181.29 M73.47 M109.09 M336.6 M17.7 M40.14 M 40.14 M Free cash flow -89.3 M-132.78 M-120.41 M-91.05 M-10.67 M54.87 M 54.87 M

MIRM

Financials

Новости

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Leerink снижает целевую цену акций Mirum Pharmaceuticals до $118

Evercore ISI подтверждает рейтинг Outperform для Mirum Pharmaceuticals

Leerink cuts Mirum Pharmaceuticals stock price target to $118

Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform

Акции Mirum Pharmaceuticals падают на фоне прогноза расходов на R&D

Mirum Pharmaceuticals stock falls on R&D spending outlook, RBC reiterates Outperform

Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues

Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)

Citizens cuts Mirum Pharmaceuticals stock price target on valuation

Mirum Pharmaceuticals: доходы оказались ниже прогнозов, прибыльa обогнал ожидания в Q4

Mirum Pharmaceuticals earnings missed by $0.08, revenue topped estimates